Rivista
/
/
Induktion av invasiva Transitional Cell blåskarcinom i immuna intakt human MUC1 transgena möss: En modell för immunterapi utveckling
JoVE Journal
Medicina
È necessario avere un abbonamento a JoVE per visualizzare questo.  Accedi o inizia la tua prova gratuita.
JoVE Journal Medicina
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
DOI:

11:02 min

October 30, 2013

, , , , , , ,

Capitoli

  • 00:05Titolo
  • 01:43Bladder Cancer Induction and Vaccination Treatments
  • 02:49Monitoring and Sample Collection
  • 04:11Multiplex Fluorometric Microbead Immunoassay
  • 06:37IFN-γ/IL-4 ELISpot Preparation and Analysis
  • 08:07Representative Transitional Cell Bladder Carcinoma Induction Results
  • 10:39Conclusion

Summary

Traduzione automatica

En N-butyl-N-(4-hydroxibutyl) nitrosamin-inducerad blåscancer modell utvecklades i human mucin 1 (MUC1) transgena möss för att testa MUC1-riktad immunterapi. Efter administrering av en MUC1-riktad peptidvaccin, var en cytotoxisk T lymfocytsvaret MUC1 bekräftades genom mätning av serum cytokinnivåer och T-cell specifik aktivitet.

Video correlati

Read Article